Author:
Yin Feng,Ling Yonghua,Martin Jason,Narayanaswamy Rohini,McIntosh Lisa,Li Fumin,Liu Guowen
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference25 articles.
1. The emergence of dihydroorotate dehydrogenase (DHODH) as a therapeutic target in acute myeloid leukemia;Sykes;Expert Opin. Ther. Targets,2018
2. Activity of a novel 4-quinolinecarboxylic acid, NSC 368390 [6-fluoro-2-(2’-fluoro-1,1’-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid sodium salt], against experimental tumors;Dexter;Cancer Res.,1985
3. Phase I clinical and pharmacokinetic trial of Brequinar sodium (DuP 785; NSC 368390);Arteaga;Cancer Res.,1989
4. A phase I clinical and pharmacokinetic study of brequinar sodium, DUP 785 (NSC 368390), using a weekly and a biweekly schedule;Bork;Eur. J. Cancer Clin. Oncol.,1989
5. Pharmacokinetics of Brequinar sodium (NSC 368390) in patients with solid tumors during a phase I study;Schwartsmann;Eur. J. Cancer Clin. Oncol.,1989
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献